Literature DB >> 24161931

Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure.

Ellen Dirkx1, Monika M Gladka, Leonne E Philippen, Anne-Sophie Armand, Virginie Kinet, Stefanos Leptidis, Hamid El Azzouzi, Kanita Salic, Meriem Bourajjaj, Gustavo J J da Silva, Servé Olieslagers, Roel van der Nagel, Roel de Weger, Nicole Bitsch, Natasja Kisters, Sandrine Seyen, Yuka Morikawa, Christophe Chanoine, Stephane Heymans, Paul G A Volders, Thomas Thum, Stefanie Dimmeler, Peter Cserjesi, Thomas Eschenhagen, Paula A da Costa Martins, Leon J De Windt.   

Abstract

Although aberrant reactivation of embryonic gene programs is intricately linked to pathological heart disease, the transcription factors driving these gene programs remain ill-defined. Here we report that increased calcineurin/Nfat signalling and decreased miR-25 expression integrate to re-express the basic helix-loop-helix (bHLH) transcription factor dHAND (also known as Hand2) in the diseased human and mouse myocardium. In line, mutant mice overexpressing Hand2 in otherwise healthy heart muscle cells developed a phenotype of pathological hypertrophy. Conversely, conditional gene-targeted Hand2 mice demonstrated a marked resistance to pressure-overload-induced hypertrophy, fibrosis, ventricular dysfunction and induction of a fetal gene program. Furthermore, in vivo inhibition of miR-25 by a specific antagomir evoked spontaneous cardiac dysfunction and sensitized the murine myocardium to heart failure in a Hand2-dependent manner. Our results reveal that signalling cascades integrate with microRNAs to induce the expression of the bHLH transcription factor Hand2 in the postnatal mammalian myocardium with impact on embryonic gene programs in heart failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24161931     DOI: 10.1038/ncb2866

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  64 in total

1.  Expression of the receptor tyrosine kinase gene EphB3 during early stages of chick embryo development.

Authors:  R K Baker; A K Vanderboom; G W Bell; P B Antin
Journal:  Mech Dev       Date:  2001-06       Impact factor: 1.882

Review 2.  Sizing up the heart: development redux in disease.

Authors:  Eric N Olson; Michael D Schneider
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

Review 3.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

4.  Cardiac neural crest expression of Hand2 regulates outflow and second heart field development.

Authors:  Yuka Morikawa; Peter Cserjesi
Journal:  Circ Res       Date:  2008-11-13       Impact factor: 17.367

5.  MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.

Authors:  Jayavarshni Ganesan; Deepak Ramanujam; Yassine Sassi; Andrea Ahles; Claudia Jentzsch; Stanislas Werfel; Simon Leierseder; Xavier Loyer; Mauro Giacca; Lorena Zentilin; Thomas Thum; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  Circulation       Date:  2013-04-26       Impact factor: 29.690

6.  FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions.

Authors:  I J Mason; F Fuller-Pace; R Smith; C Dickson
Journal:  Mech Dev       Date:  1994-01       Impact factor: 1.882

7.  Hand2 determines the noradrenergic phenotype in the mouse sympathetic nervous system.

Authors:  Yuka Morikawa; Fabien D'Autréaux; Michael D Gershon; Peter Cserjesi
Journal:  Dev Biol       Date:  2007-04-27       Impact factor: 3.582

8.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

9.  Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Authors:  Norimichi Koitabashi; Djahida Bedja; Ari L Zaiman; Yigal M Pinto; Manling Zhang; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

10.  A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart.

Authors:  D G McFadden; J Charité; J A Richardson; D Srivastava; A B Firulli; E N Olson
Journal:  Development       Date:  2000-12       Impact factor: 6.868

View more
  47 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 2.  MicroRNAs in cardiovascular ageing.

Authors:  Timon Seeger; Reinier A Boon
Journal:  J Physiol       Date:  2015-07-05       Impact factor: 5.182

Review 3.  The Role of MicroRNAs in the Cardiac Response to Exercise.

Authors:  Xiaojun Liu; Colin Platt; Anthony Rosenzweig
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 4.  MicroRNA-based therapy in cardiology.

Authors:  J Fiedler; S Batkai; T Thum
Journal:  Herz       Date:  2014-03       Impact factor: 1.443

Review 5.  Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders.

Authors:  Zhen-Yu Yao; Wen-Bin Chen; Shan-Shan Shao; Shi-Zhan Ma; Chong-Bo Yang; Meng-Zhu Li; Jia-Jun Zhao; Ling Gao
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

6.  SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis.

Authors:  Mohsen Sarikhani; Sangeeta Maity; Sneha Mishra; Aditi Jain; Ankit K Tamta; Venkatraman Ravi; Mrudula S Kondapalli; Perumal A Desingu; Danish Khan; Shweta Kumar; Swathi Rao; Meena Inbaraj; Anwit S Pandit; Nagalingam Ravi Sundaresan
Journal:  J Biol Chem       Date:  2018-02-13       Impact factor: 5.157

Review 7.  The role of miRNA regulation in fetal cardiomyocytes, cardiac maturation and the risk of heart disease in adults.

Authors:  Mitchell C Lock; Ross L Tellam; Kimberley J Botting; Kimberley C W Wang; Joseph B Selvanayagam; Doug A Brooks; Mike Seed; Janna L Morrison
Journal:  J Physiol       Date:  2018-06-28       Impact factor: 5.182

8.  Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters.

Authors:  Loredan S Niculescu; Natalia Simionescu; Elena V Fuior; Camelia S Stancu; Mihaela G Carnuta; Madalina D Dulceanu; Mina Raileanu; Emanuel Dragan; Anca V Sima
Journal:  Mol Biol Rep       Date:  2018-05-03       Impact factor: 2.316

9.  Hand Factors in Cardiac Development.

Authors:  Rajani M George; Anthony B Firulli
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

10.  Hand2 elevates cardiomyocyte production during zebrafish heart development and regeneration.

Authors:  Yocheved L Schindler; Kristina M Garske; Jinhu Wang; Beth A Firulli; Anthony B Firulli; Kenneth D Poss; Deborah Yelon
Journal:  Development       Date:  2014-07-18       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.